S4 Ep123: On Kidney Cancer Advocacy: ‘There’s Only One Way to Go, and That’s Forward’
Cancer Horizons3 Mars 2022

S4 Ep123: On Kidney Cancer Advocacy: ‘There’s Only One Way to Go, and That’s Forward’

After being diagnosed with kidney cancer — which was a possible result of exposure to the 9/11 terrorist attacks in New York City – Steven Edwards realized that he had to be his own advocate. Pivotal to his advocacy was asking questions and getting as many professional opinions as possible.
“I probably would consider whether it was the right doctor for me in the first place if a doctor was upset about getting a second opinion, because it’s all about gathering education and becoming educated yourself,” Edwards said in an interview with CURE®.
Edwards went through multiple different treatments, including the participation on a clinical trial, and continues to push for better outcomes for himself and other survivors through being an advocate for the Kidney Cancer Association and KidneyCAN.
Through cancer setbacks like a diagnosis of metastatic disease in 2017, classifying Edwards’ disease as stage 4, he continues to seek information in this rapidly changing field. After all, “There’s only way to go, and that’s forward,” Edwards said.
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(295)

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berg...

31 Dec 202514min

S7 Ep1: The Importance of Spotting Endometrial Cancer

S7 Ep1: The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

18 Mars 202510min

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

17 Sep 202419min

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another ca...

4 Mars 20247min

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, an...

4 Mars 202410min

S6 Ep20: FDA Approvals from February 2024

S6 Ep20: FDA Approvals from February 2024

Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers. ...

23 Feb 20246min

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

Last week, we saw some FDA approvals for a new drug regimens, as well as some expert opinion about cancer vaccines. Additionally research touched upon the potential benefit of concurrent ctDNA and tum...

19 Feb 20249min

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews. Also last week, we covered researc...

12 Feb 20247min

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
medicinvetarna
rss-ufobortom-rimligt-tvivel
svd-nyhetsartiklar
rss-vetenskapsradion
rss-vetenskapsradion-2
bildningspodden
vetenskapsradion
rss-spraket
rss-broccolipodden-en-podcast-som-inte-handlar-om-broccoli
paranormalt-med-caroline-giertz
rss-ronden
sexet
dumforklarat
rss-odla
barnpsykologerna
rss-tidslinjen-podcast